ACCESSWIRE
20 Sep 2023, 19:43 GMT+10
WASHINGTON, D.C. / ACCESSWIRE / September 20, 2023 / MMJ International Holdings announced today, that it has submitted to the U.S. Food and Drug Administration (FDA) MMJ's cannabis formulation requested responses for the agency's review. The FDA had notified MMJ International Holdings of a CMC (chemistry, manufacturing, control) issue which the company completed the required complex scientific research needed to begin its clinical trials in Multiple Sclerosis and Huntington's Disease.
Dr. Elio Mariani, MMJ's chief scientific stated, 'MMJ believes that the responses submitted to the FDA today fully addresses the CMC questions pertaining to its all-natural plant, soft gel capsule API of THC and CBD, for use in human clinical trials.'
Duane Boise, President stated, 'Once approved, MMJ International Holdings, MMJ BioPharma Cultivation, and MMJ Biopharma Labs will be one of a very few federally legal DEA, FDA approved companies, vertically integrated, with the infrastructure to support pharmaceutical development of botanical drugs for clinical trials.'
MMJ BioPharma Labs has been issued a DEA Analytical Lab Registration for schedule 1 drugs with the primary focus on cannabis research and development. With this DEA approval, MMJ Biopharma Labs becomes one of the few federally legal labs dedicated to cannabis extraction, research, and development.
This DEA approval allows MMJ BioPharma Labs the ability to manufacture, transport, import, and export cannabis domestically and internationally to DEA registrants and companies registered in their respective international jurisdictions.
In spite of all these accomplishments and President Biden's Marijuana Research Act approval the DEA continues to delay MMJ BioPharma Cultivations API Bulk Manufacturing registration approval which is the subject of litigation.
Tim Moynahan, chairman stated 'MMJ has accomplished many major milestones which positions it as a leader in the cannabis pharmaceutical development arena. This being the most significant because safe, reproducible marijuana medicine is needed to set the standard for reproducible results. MMJ's clinical trials will prove efficacy and this is what the team has accomplished.'
MMJ recognizes that there is significant public interest in cannabis and cannabis-derived compounds. The MMJ team continues to work diligently with universities and scientist to fill in the knowledge gaps about the science, safety and quality of their products. We are committed to advancing our marijuana cultivation, lab formulations and clinical trials through an approach that is in line with our mission to prioritizes public health, fosters innovation, and promotes consumer confidence.
Duane Boise the companies President recently speaking at the Benzinga Cannabis Forum mentioned that 'as federal legalization of the state to state recreational and medicinal marijuana businesses is not imminent, MMJ's strategy of pharmaceutical drug development and clinical trials will show itself as the new cannabis 3.0.'
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
media@mmjih.com
203-231-8583
SOURCE: MMJ International Holdings
Get a daily dose of California Telegraph news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to California Telegraph.
More InformationWASHINGTON DC - In a major blow to U.S. President Joe Biden, less that a year out from the November ...
TOKYO, Japan: This week, the U.S. Air Force said that divers have discovered the wreckage and the remains of five ...
VANDENBERG, California: South Korea successfully launched its inaugural military spy satellite, following North Korea's recent claim of deploying its own ...
JAKARTA, Indonesia: The death toll from the eruption of Indonesia's Marapi volcano surged to 22 as rescuers discovered additional climbers ...
In September, Tamir Pardo, who headed the Mossad, Israel's national intelligence agency, under Prime Minister Benjamin Netanyahu from 2011 to ...
HONOLULU, Hawaii: U.S. Navy officials say that it would cost some $1.5 million to salvage a P-8A jet plane that ...
NEW YORK, New York - AI set the scene for solid gains in technology shares on Thursday. Demand for Alphabet ...
WASHINGTON D.C.: To help reduce car collisions with wildlife and help animals safely cross roadways, the U.S. Transportation Department has ...
BRUSSELS, Belgium: To address power shortages at electric vehicle (EV) charging stations, last week, the European Commission announced plans to ...
BEIJING, China: Falling hog prices, mounting losses and rising debt are putting pressure on the biggest pig breeders in China, ...
NEW YORK, New York - A decline in labor costs as measured by ADP failed to boost U.S. Markets Wednesday."ADP's ...
WASHINGTON D.C.: A U.S. auto safety regulator said this week it is opening an investigation into 73,000 Chevrolet Volt plug-in ...